Avalon Pharmaceutical to distribute MediWound's NexoBrid in Latin America
Biopharmaceutical company MediWound agreed to a deal giving Avalon Pharmaceutical S.A. the rights to market and distribute its severe burn treatment product NexoBrid is several Latin American countries. Avalon will work with MediWound to provide individuals in Chile, Colombia, Ecuador Panama and Peru access to the topically applied product that is used to treat severe burns. Read More »